Vipin Lohiya, M.D.

Piedmont Cancer Institute

Oncology: Hematology

Fayetteville and Stockbridge

Most recent review: 1 week ago Recent
4.9
565 Ratings
246 Comments

Dr. Vipin Lohiya diagnoses and treats a variety of cancers as well as blood disorders due to his experience with hematology and oncology. Dr. Lohiya provides a patient-centered approach which involves both communication with you and coordination with your other doctors.

4.9
565 Ratings
246 Comments

Dr. Vipin Lohiya diagnoses and treats a variety of cancers as well as blood disorders due to his experience with hematology and oncology. Dr. Lohiya provides a patient-centered approach which involves both communication with you and coordination with your other doctors.

The reviews listed below were collected independently of Piedmont Cancer Institute through rater8. Each review represents an authentic and verified patient experience.

A nice, professional, sophisticated, and patient doctor with a bit sense of humor!!

(1 week ago) Apr-2026

Best cancer Dr! He is our angel

(2 weeks ago) Apr-2026

Dr. Lohiya seems to genuinely care about his patients care. He is patient, listens to patient concerns and is knowledgeable in his specialty.

(2 weeks ago) Apr-2026

THE BEST! I truly appreciate his time in explaining everything to me, and the treatments he has provided to improve my health conditions, and quality of life.

(2 weeks ago) Apr-2026

Thank you Dr. Louis and Dr Wooley

(2 weeks ago) Apr-2026

Dr Lohiiya is such a pleasant person. He expressed real concern. I felt seen and heard (which is refreshing for someone with 2 teen girls)😅 Thank Dr Lohiya

(2 weeks ago) Apr-2026

Thank you Dr Lohiya!! You are an outstanding Doctor.

(3 weeks ago) Apr-2026

Excellent Doctor. Takes time with his patients.

(1 month ago) Mar-2026

Very concerned about your family too obtain information to aid you in your medical journey

(1 month ago) Mar-2026

Very pleasant and professional. Excellent bedside manners. Caring. I highly recommend Dr Lohiya

(1 month ago) Mar-2026
Read More